Literature DB >> 17445087

Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?

C Robin Hiley1, Pui Man Hoi.   

Abstract

Oleamide (cis-9,10-octadecenoamide), a fatty acid primary amide discovered in the cerebrospinal fluid of sleep-deprived cats, has a variety of actions that give it potential as a signaling molecule, although these actions have not been extensively investigated in the cardiovascular system. The synthetic pathway probably involves synthesis of oleoylglycine and then conversion to oleamide by peptidylglycine alpha-amidating monooxygenase (PAM); breakdown of oleamide is by fatty acid amide hydrolase (FAAH). Oleamide interacts with voltage-gated Na(+) channels and allosterically with GABA(A) and 5-HT(7) receptors as well as having cannabinoid-like actions. The latter have been suggested to be due to potentiation of the effects of endocannabinoids such as anandamide by inhibiting FAAH-mediated hydrolysis. This might underlie an "entourage effect" whereby co-released endogenous nonagonist congeners of endocannabinoids protect the active molecule from hydrolysis by FAAH. However, oleamide has direct agonist actions at CB(1) cannabinoid receptors and also activates the TRPV1 vanilloid receptor. Other actions include inhibition of gap-junctional communication, and this might give oleamide a role in myocardial development. Many of these actions are absent from the trans isomer of 9,10-octadecenoamide. One of the most potent actions of oleamide is vasodilation. In rat small mesenteric artery the response does not involve CB(1) cannabinoid receptors but another pertussis toxin-sensitive, G protein-coupled receptor, as yet unidentified. This receptor is sensitive to rimonabant and O-1918, an antagonist at the putative "abnormal-cannabidiol" or endothelial "anandamide" receptors. Vasodilation is mediated by endothelium-derived nitric oxide, endothelium-dependent hyperpolarization, and also through activation of TRPV1 receptors. A physiological role for oleamide in the heart and circulation has yet to be demonstrated, as has production by cells of the cardiovascular system, but this molecule has a range of actions that could give it considerable modulatory power.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445087     DOI: 10.1111/j.1527-3466.2007.00004.x

Source DB:  PubMed          Journal:  Cardiovasc Drug Rev        ISSN: 0897-5957


  13 in total

1.  Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules.

Authors:  Dominik P Waluk; Filip Sucharski; Laszlo Sipos; Jerzy Silberring; Mary C Hunt
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

2.  Effects of Oleamide on the Vasomotor Responses in the Rat.

Authors:  Carlos Hernández-Díaz; Marco Antonio Juárez-Oropeza; Dieter Mascher; Natalia Pavón; Ignacio Regla; María Cristina Paredes-Carbajal
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 3.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

Review 4.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 5.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

Review 6.  Endocannabinoids and the heart.

Authors:  C Robin Hiley
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

7.  Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.

Authors:  Varadarajan Sudhahar; Sean Shaw; John D Imig
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

8.  Metabolite Profiling of 5'-AMP-Induced Hypometabolism.

Authors:  Zhaoyang Zhao; Anita Van Oort; Zhenyin Tao; William G O'Brien; Cheng Chi Lee
Journal:  Metabolomics       Date:  2014-02-01       Impact factor: 4.290

9.  Metabolic Changes in Brain Slices over Time: a Multiplatform Metabolomics Approach.

Authors:  Carolina Gonzalez-Riano; Silvia Tapia-González; Gertrudis Perea; Candela González-Arias; Javier DeFelipe; Coral Barbas
Journal:  Mol Neurobiol       Date:  2021-03-02       Impact factor: 5.590

10.  Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations.

Authors:  Anusha Jayaraman; Praveen Kumar; Silvia Marin; Pedro de Atauri; Francesca Mateo; Timothy M Thomson; Josep J Centelles; Stewart F Graham; Marta Cascante
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.